UPDATE : Monday, July 13, 2020
상단여백
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint
Vivozon said that it has started on a design change for its phase 3b clinic...
by Lee Han-soo  |  2020-01-13 16:22
라인
Lilly secures atopic dermatitis drug through Dermira acquisition
Lilly has enhanced its immune disease pipelines by obtaining the rights to ...
by Kim Yun-mi  |  2020-01-13 14:05
라인
Latecomer Bavencio improves overall survival in bladder cancer trial
Bavencio (ingredient: avelumab), a latecomer in the Tecentriq-led immune ch...
by Kim Yun-mi  |  2020-01-10 14:23
라인
HLB gets UAE’s nod for joint company with local partner
Elevar therapeutics, a U.S. subsidiary of HLB, said that the United Arab Em...
by Lee Han-soo  |  2020-01-08 16:31
라인
Daewoong, Avacta to establish joint venture
Daewoong Pharmaceutical said that it plans to set up a joint venture (JV) w...
by Lee Han-soo  |  2020-01-08 12:25
라인
Genexine licenses out immunosuppressant candidate to GenNBio
Genexine said that it has licensed out BSF-110, a dual-fusion immunosuppres...
by Lee Han-soo  |  2020-01-07 17:35
라인
Mundipharma to market Biosolution's knee cartilage defect treatment
Biosolution said that it has signed an exclusive sales agreement with Mundi...
by Lee Han-soo  |  2020-01-07 16:11
라인
Fenbendazole craze expands to human parasiticide
Following the craze over fenbendazole, a dog deworming drug, in treating ca...
by Lee Han-soo  |  2020-01-07 12:33
라인
Eliquis price cut delayed amid prolonged administrative suit
The Ministry of Health and Welfare’s order in June to cut the price of BMS ...
by Kim Yun-mi  |  2020-01-07 11:32
라인
Chinese drugmaker Mebo establishes branch in Korea
Mebo Group, a Chinese firm specializing in regenerative medicine, has estab...
by Lee Han-soo  |  2020-01-06 14:40
라인
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
After the regulator kicked ranitidine and nizatidine out of the market due ...
by Jeong Sae-im  |  2020-01-03 17:56
라인
Bukwang, Sanofi Aventis Korea to co-promote hypertension med
Bukwang Pharmaceutical said that it would promote and market Aprovel and Co...
by Lee Han-soo  |  2020-01-03 17:55
라인
Daewoong launches oral typhoid fever vaccine
Daewoong Pharmaceutical said that it has launched Vivotif, an oral typhoid ...
by Lee Han-soo  |  2020-01-03 17:55
라인
[New Year Special] Rise of digital therapeutics to change healthcare scene for good
If a person gets sick, he or she visits a doctor, gets a prescription, take...
by Lee Han-soo  |  2020-01-03 14:57
라인
SK Bioscience’s influenza vaccine nabs WHO certification
SK Bioscience said that the World Health Organization (WHO) has granted pre...
by Lee Han-soo  |  2020-01-03 14:14
라인
Daewoong to kick off P3 trial of Nabota in China
Daewoong Pharmaceutical said Tuesday that it held a meeting with Chinese re...
by Lee Han-soo  |  2020-01-02 17:36
라인
FDA OKs Huons' generic of topic anesthetic injection
Huons said that the U.S. Food and Drug Administration has approved the comp...
by Lee Han-soo  |  2020-01-02 14:30
라인
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market
Medytox said that the Ministry of Food and Drug Safety has approved to sell...
by Lee Han-soo  |  2020-01-02 12:12
라인
Korean biopharmaceuticals competitively move abroad to expand global presence
Local pharmaceutical companies are actively advancing to overseas markets. ...
by Jeong Sae-im  |  2019-12-30 17:20
라인
Migraine drug market heats up with Ubrelvy’s arrival
After Lilly’s acute migraine drug Reyvow (ingredient: lasmiditan) obtained ...
by Kim Yun-mi  |  2019-12-27 11:57
여백
여백
여백
Back to Top